Explore
Validate
LearnH00057492-M01
antibody from Novus Biologicals
Targeting: ARID1B
6A3-5, BAF250b, DAN15, ELD/OSA1, KIAA1235, p250R
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Western blot [1]
- ELISA [1]
- Immunocytochemistry [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- H00057492-M01 - Provider product page
- Provider
- Novus Biologicals
- Proper citation
- Novus Cat#H00057492-M01, RRID:AB_536904
- Product name
- Mouse Monoclonal ARID1B Antibody
- Antibody type
- Monoclonal
- Description
- IgG purified. ARID1B - AT rich interactive domain 1B (SWI1-like)
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Vial size
- 0.1 mg
- Storage
- Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
Submitted references Chemical Inhibitors of a Selective SWI/SNF Function Synergize with ATR Inhibition in Cancer Cell Killing.
Undifferentiated Endometrial Carcinomas Show Frequent Loss of Core Switch/Sucrose Nonfermentable Complex Proteins.
The genomic landscape of schwannoma.
Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas.
Frequent loss of the expression of multiple subunits of the SWI/SNF complex in large cell carcinoma and pleomorphic carcinoma of the lung.
Loss of ARID1A, ARID1B, and ARID2 Expression During Progression of Gastric Cancer.
Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer.
Chory EJ, Kirkland JG, Chang CY, D'Andrea VD, Gourisankar S, Dykhuizen EC, Crabtree GR
ACS chemical biology 2020 Jun 19;15(6):1685-1696
ACS chemical biology 2020 Jun 19;15(6):1685-1696
Undifferentiated Endometrial Carcinomas Show Frequent Loss of Core Switch/Sucrose Nonfermentable Complex Proteins.
Köbel M, Hoang LN, Tessier-Cloutier B, Meng B, Soslow RA, Stewart CJR, Lee CH
The American journal of surgical pathology 2018 Jan;42(1):76-83
The American journal of surgical pathology 2018 Jan;42(1):76-83
The genomic landscape of schwannoma.
Agnihotri S, Jalali S, Wilson MR, Danesh A, Li M, Klironomos G, Krieger JR, Mansouri A, Khan O, Mamatjan Y, Landon-Brace N, Tung T, Dowar M, Li T, Bruce JP, Burrell KE, Tonge PD, Alamsahebpour A, Krischek B, Agarwalla PK, Bi WL, Dunn IF, Beroukhim R, Fehlings MG, Bril V, Pagnotta SM, Iavarone A, Pugh TJ, Aldape KD, Zadeh G
Nature genetics 2016 Nov;48(11):1339-1348
Nature genetics 2016 Nov;48(11):1339-1348
Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas.
Coatham M, Li X, Karnezis AN, Hoang LN, Tessier-Cloutier B, Meng B, Soslow RA, Blake Gilks C, Huntsman DG, Stewart CJ, Postovit LM, Köbel M, Lee CH
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 Dec;29(12):1586-1593
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 Dec;29(12):1586-1593
Frequent loss of the expression of multiple subunits of the SWI/SNF complex in large cell carcinoma and pleomorphic carcinoma of the lung.
Yoshimoto T, Matsubara D, Nakano T, Tamura T, Endo S, Sugiyama Y, Niki T
Pathology international 2015 Nov;65(11):595-602
Pathology international 2015 Nov;65(11):595-602
Loss of ARID1A, ARID1B, and ARID2 Expression During Progression of Gastric Cancer.
Aso T, Uozaki H, Morita S, Kumagai A, Watanabe M
Anticancer research 2015 Dec;35(12):6819-27
Anticancer research 2015 Dec;35(12):6819-27
Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer.
Shain AH, Giacomini CP, Matsukuma K, Karikari CA, Bashyam MD, Hidalgo M, Maitra A, Pollack JR
Proceedings of the National Academy of Sciences of the United States of America 2012 Jan 31;109(5):E252-9
Proceedings of the National Academy of Sciences of the United States of America 2012 Jan 31;109(5):E252-9
No comments: Submit comment
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Western Blot: ARID1B Antibody (2D2) [H00057492-M01] - ARID1B monoclonal antibody (M01), clone 2D2 Analysis of ARID1B expression in Hela S3 NE.
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- ELISA: ARID1B Antibody (2D2) [H00057492-M01] - Detection limit for recombinant GST tagged ARID1B is approximately 0.03ng/ml as a capture antibody.
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunocytochemistry/Immunofluorescence: ARID1B Antibody (2D2) [H00057492-M01] - Analysis of monoclonal antibody to ARID1B on HeLa cell. Antibody concentration 10 ug/ml.
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: ARID1B Antibody (2D2) [H00057492-M01] - Analysis of monoclonal antibody to ARID1B on formalin-fixed paraffin-embedded human kidney. Antibody concentration 3 ug/ml.
